Evaluate the effectiveness and safety of elcatonin in the treatment of osteoporosis with lumbar canal stenosis: a multicenter, double-minded, randomized, placebo cnotrolled clinical study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-14005501

Enrollment

Unknown

Registered

2014-11-13

Start date

2014-11-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis with lumbar canal stenosis

Interventions

Two groups:Elcatonin Injection

Eligibility

Sex/Gender

All

Age

50 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) patients suffering from primary osteoporosis with lumbar spinal stenosis; 2) To be aged older than 50 years; 3) Patients must present with clinical symptoms of neurogenic claudication; 4) limiting walking distance to less than 500m; 5) voluntarily signed informed consent.

Exclusion criteria

Exclusion criteria: Hypersensitivity to elcatonin Prior use of calcitonin for LCS; present use for osteoporosis Past or present lower extremity peripheral vascular disease Prior lumbar canal stenosis surgery (laminectomy with or without fusion) Moderate to severe concomitant arthritis of the knee or hip Concomitant lumbar disc herniation; Histrory of cerebral hemorrhage or bleeding tendency; Serious coronary heart disease or heart and lung failure; Severe psychiatric disorder; Patients that researchers considered unsuitable.

Design outcomes

Primary

Measure	Time frame
walking distance;VAS Scale;	—

Secondary

Measure	Time frame
Lower limb pain or numbness scales;AE incidence;	—

Countries

China

Contacts

Public ContactTang Hai

tanghai@medmail.com.cn+86 010-63139163

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026